Ischemic heart disease Board decisions

The Board denied service connection for eczema, allergic rhinitis, and pulmonary hypertension with valvular heart disease. The claims for service connection of various other conditions were remanded.

The Board remands the claims for further development, including obtaining private medical records and scheduling an examination.

The Board denied service connection for coronary artery disease, hypertensive heart disease with congestive heart failure, supraventricular arrhythmia, valvular heart disease, and left ventricular assist device as the evidence did not show that these conditions were incurred during or caused by active military service.

The Board remands the claim for service connection for heart disease to correct a duty to assist error, specifically to obtain a medical opinion addressing whether the Veteran's ankle disorder aggravated his heart disease and to obtain relevant Federal worker's compensation records.

The Board denied earlier effective dates for the award of service connection for hypertension and CAD, granted a 10 percent evaluation for hypertension, and remanded several other claims.

The Board denied the veteran's claims for higher ratings and earlier effective dates, except for an earlier effective date for service connection of lower extremity peripheral neuropathy.

The Board denied the Veteran's request for an earlier effective date prior to August 1, 2024, for a rating of 60 percent for ischemic heart disease, CAD, myocardial infarction, unstable angina, with cardiomyopathy and heart block.

The Board granted service connection for coronary artery disease, diabetes mellitus type II, and left and right lower extremity diabetic neuropathy due to exposure to contaminated drinking water at Camp Lejeune during service. Service connection for obstructive sleep apnea was remanded.

The Board granted service connection for pacemaker implantation as secondary to the Veteran's service-connected coronary artery disease and awarded a 100 percent rating for coronary artery disease, rendering the issue of TDIU moot.

The Board denied entitlement to an evaluation in excess of 30 percent for coronary artery disease (CAD) from April 18, 2021 to March 5, 2024.

The Board granted service connection for the cause of the Veteran's death, attributing it to active military service and exposure to toxins.

The Veteran's service-connected disabilities, including PTSD and other conditions, have prevented him from securing or following a substantially gainful occupation.

The Board remands the claims for service connection for diabetes mellitus type II and atherosclerotic heart disease to obtain additional evidence, as the Veteran's service treatment records are unavailable and there is insufficient medical evidence to determine the etiology of these conditions.

The Board granted earlier effective dates of March 29, 2016, for the grants of service connection for multiple conditions including hypertension, peripheral vascular disease, scars, kidney disease, femoral artery occlusion, lacunar stroke, erectile dysfunction, cerebral vascular disease, and valvular heart disease.

The Board granted service connection for chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD), as secondary to the Veteran's service-connected conditions.

The Board denied service connection for coronary artery disease, hypertension, and sinusitis as the evidence did not support a finding that these conditions were incurred in or aggravated by active service.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for ischemic heart disease and diabetes mellitus type II, both presumed to be related to exposure to herbicides during ACDUTRA at Fort McClellan. The claims for benign prostatic hyperplasia, headaches, and skin cancer were remanded.

The Board denied service connection for a heart condition due to the lack of evidence showing a current disability and no chronic symptoms within the past several years. The hypertension issue was remanded for further development.

The Board remands the claims for service connection for coronary artery disease, bladder cancer, hypertension, and prostate cancer to correct a duty to assist error regarding the Veteran's asserted in-service exposure to herbicide agents based on the information included in the claims file.